Dopamine-β-hydroxylase (DBH) is thought to be discharged together with catecholamine from the adrenal medulla and sympathetic nerve endings by a process of exocytosis. Since insulin-induced hypoglycemia is a stimulus associated with markedly enhanced catecholamine secretion, we investigated whether there was any difference in the response of plasma DBH activity to acute hypoglycemia between normal subjects and asthmatic patients. Regular insulin (0.1 unit/kg) was intravenously injected to 8 asthmatic and 10 normal subjects. Blood samples were obtained before and 30, 60, 90 and 120 min after insulin injection and checked for blood glucose and plasma DBH activity. Urine was collected for the period of 2 hours before and after insulin injection and assayed for catecholamines. There was no significant difference in the decrease of blood glucose between two groups. No significant increase of urinary norepinephrine was observed, but urinary epinephrine was markedly increased in both groups. These findings suggest that release of catecholamines following insulin induced hypoglycemia was similar in the groups. Percent change of post-injection plasma DBH activity was not significant in normal subjects. In asthmatic patients, however, this enzyme activity decreased significantly at 60 and 90 min after injection as compared with the initial values. These results suggest that as no significant increase of plasma DBH activity was observed in response to acute hypoglycemia, plasma DBH measurement is not necessarily suitable for assessing sympatho-adrenomedullary function in the groups studied, and that DBH metabolism, including release from the nerve endings and disappearance from circulation, might be different in asthmatic patients from that in normal subjects.
View full abstract